Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation

American Journal of Transplantation

Volumn 9, Issue 2, 2009, Pages 301-308

  Shaked, A ^a   Ghobrial, R M ^b,k   Merion, R M ^c   Shearon, T H ^d   Emond, J C ^e   Fair, J H ^f,l   Fisher, R A ^g   Kulik, L M ^h   Pruett, T L ⁱ   Terrault, N A ^j  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e University of North Carolina ^*  (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k HOUSTON METHODIST HOSPITAL   (United States)

^l CEDARS SINAI MEDICAL CENTER   (United States)

more..

Author keywords

Acute rejection; Cold ischemia injury; LDLT; Liver regeneration

Indexed keywords

ANTIBODY; CYCLOSPORIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT FAILURE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER GRAFT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL;

ACUTE DISEASE; COHORT STUDIES; DONOR SELECTION; FEMALE; GRAFT REJECTION; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 58849085921     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02487.x     Document Type: Article

References (24)

1. Kim MS, Kim DK, Myoung SM et al. Chronologically different impacts of immunologic and non-immunologic risk factors on renal allograft function. Clin Transplant 2005 19 : 742 750.
2. Van Der Hoeven JA, Molema G, Ter Horst GJ et al. Relationship between duration of brain death and hemodynamic instability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003 64 : 1874 1882.
3. Siddiqi N, McBride MA, Hariharan S. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int 2004 65 : 1906 1913.
4. Krieger NR, Becker BN, Heisey DM et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003 75 : 1677 1682.
5. Cosio FG, Grande JP, Larson TS et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005 5 : 1130 1136.
6. Borozan I, Chen L, Sun J et al. Gene expression profiling of acute liver stress during living donor liver transplantation. Am J Transplant 2006 6 : 806 824.
7. Debonera F, Wang G, Xie J et al. Severe preservation injury induces Il-6/STAT3 activation with lack of cell cycle progression after partial liver graft transplantation. Am J Transplant 2004 4 : 1964 1971.
8. Shaked A, Hulbert-Shearon TE, Everhart J, Merion RM for the A2ALL Investigator Study Group. Rejection is decreased among adult recipients of living donor versus cadaveric liver allografts. Am J Transplant 2004 4 (Suppl 8 268.
9. Maluf DG, Stravitz RT, Cotterell AH et al. Adult living donor versus deceased donor liver transplantation: A 6-year single center experience. Am J Transplant 2005 5 : 149 156.
10. Liu LU, Bodian CA, Gondolesi GE et al. Marked differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation 2005 80 : 1072 1080.
11. Gillespie BW, Merion RM, Ojo AO et al. Comparison of patient information in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) and the Scientific Registry of Transplant Recipients (SRTR) database. Am J Transplant 2008 8 (Suppl 2 289.
12. Schuurs TA, Morariu AM, Ottens PJ et al. Time-dependent changes in donor brain death related processes. Am J Transplant 2006 6 : 2903 2911.
13. Coulson MT, Jablonski P, Howden BO, Thomson NM, Stein AN. Beyond operational tolerance: Effect of ischemic injury on development of chronic damage in renal grafts. Transplantation 2005 80 : 353 361.
14. Opelz G, Wujciak T, Döhler B, Scherer S, Mytilineos J (Collaborative Transplant Study). HLA compatibility and organ transplant survival. Rev Immunogenet 1999 1 : 334 342.
15. Kutsogiannis DJ, Pagliarello G, Doig C, Ross H, Shemie SD. Medical management to optimize donor organ potential: Review of the literature. Can J Anaesth 2006 53 : 820 830.
16. Olthoff KM, Merion RM, Ghobrial RM et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: A report from the A2ALL consortium. Ann Surg 2005 242 : 314 323.
17. Weiss S, Kotsch K, Francuski M et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007 7 : 1584 1593.
18. De Jonge J, Kurian S, Shaked A, Salomon DR, Olthoff KM. Gene expression profiles of hepatic regeneration and metabolism in human living and deceased donor. Am J Transplant (submitted).
19. Quiroga I, McShane P, Koo DD et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006 21 : 1689 1696.
20. Simpkins CE, Montgomery RA, Hawxby AM et al. Cold ischemia time and allograft outcomes in live donor renal transplantation: Is live donor organ transport feasible? Am J Transplant 2007 7 : 99 107.
21. Taub R. Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 2004 5 : 836 847.
22. Debonera F, Krasinkas AM, Gelman AE et al. Dexamethasone inhibits early regenerative response of rat liver after cold preservation and transplantation. Hepatology 2003 38 : 1563 1572.
23. Navarro V, Herrine S, Katopes C, Colombe B, Spain CV. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: An analysis of the OPTN database. Liver Transplant 2006 12 : 652 658.
24. Sieders E, Hepkema BG, Peeters PM et al. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation. Liver Transplant 2005 11 : 1541 1549.